INVESTIGATION OF THE ASSOCIATION BETWEEN INSULIN RESISTANCE AND SOME CHARACTERISTICS IN PATIENTS WITH NEW-ONSET DIABETES AFTER KIDNEY TRANSPLANTATION

Dung Thị Thùy Nguyễn1, , Viet Thang Le1, Minh Nui Le1, Tien Son Nguyen1
1 Học viện Quân y

Main Article Content

Abstract

Objectives: To investigate insulin resistance status and its association with some characteristics in patients with new-onset diabetes after kidney transplantation (NODAT). Methods: A cross-sectional descriptive study was conducted on 81 patients with untreated NODAT and 53 age- and sex-matched healthy controls at Military Hospital 103 from October 2021 to December 2023. Clinical and laboratory characteristics were collected, and insulin resistance indices were calculated using the HOMA2 model, including insulin resistance (HOMA2-IR), insulin sensitivity (HOMA2-S), and β-cell function (HOMA2-B). Results: The median HOMA2-IR in the NODAT group was 0.95, which was significantly higher than that of the control group (0.7); p < 0.001. In contrast, both HOMA2-S and HOMA2-B were markedly reduced in the NODAT group compared to the control group (p < 0.001). Among NODAT patients, the prevalence of elevated HOMA2-IR, decreased HOMA2-S, and impaired HOMA2-B was 18.5%, 19.8%, and 27.2%, respectively. Patients with increased HOMA2-IR or reduced HOMA2-S exhibited significantly greater waist circumference, higher mean BMI, with those without these abnormalities, and the rate of increased HOMA2-IR was significant with OR 6,08 and 7,0, respectively (p < 0.05). Conclusion: Insulin resistance in NODAT patients is associated with increased waist circumference and higher BMI, 

Article Details

References

1. Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: A systematic review. Am J Physiol Renal Physiol. 2016; 311(6): F1087-F1108.
2. Cai R, Wu M, Lin M, et al. Pretransplant homeostasis model assessment of insulin resistance and fasting plasma glucose predict new-onset diabetes after renal transplant in Chinese patients. Transplant Proc. 2019; 51(3):768-773.
3. Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions. Am J Transplant. 2014 Sep; 14(9):1992-2000.
4. Pham PT, Pham PM, Pham SV, et al. New onset diabetes after transplantation (NODAT): An overview. Diabetes Metab Syndr Obes. 2011; 4:175-186.
5. Hội Tim mạch Quốc gia Việt Nam. Khuyến cáo chẩn đoán và điều trị tăng huyết áp. 2018:1-7.
6. WHO. Nutritional anemias: Tools for effective prevention and control. Geneva. 2017; 1:4-17.
7. Seo MH, LWY, Kim SS, et al. Korean society for the study of obesity guideline for the management of obesity in Korea. J Obes Metab Syndr. 2019; 28(1):40-45.
8. Ahmed SH, Biddle K, Augustine T, et al. Post-transplantation diabetes mellitus. Diabetes Ther. 2020 Apr; 11(4):779-801.
9. Bang JB, Oh CK, Kim YS, et al. Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: A multicenter prospective cohort study. Endocrinol Metab (Seoul). 2020; 35(4):820-829.
10. Hardy OT, Czech MP, Corvera S, et al. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012 Apr; 19(2):81-87.